Clinical Trials Sponsored by Fate Therapeutics
Total 6353 results
-
Osiris TherapeuticsTerminatedChronic Diabetic Foot UlcersUnited States
-
PTC TherapeuticsCompletedHepatic ImpairmentUnited States
-
PTC TherapeuticsCompletedHealthy VolunteersUnited States
-
Osiris TherapeuticsCompleted
-
Celldex TherapeuticsCompleted
-
Entasis TherapeuticsCompletedAcinetobacter Baumannii InfectionAustralia
-
Karuna TherapeuticsCompletedSchizophreniaUnited States
-
United TherapeuticsWithdrawnPulmonary Hypertension Associated With Sickle Cell Disease
-
Osiris TherapeuticsTerminated
-
vTv TherapeuticsCompleted
-
Intarcia TherapeuticsCompletedType 2 DiabetesFinland, United States, Bulgaria, Poland, South Africa, Denmark, Turkey, Slovakia, Germany
-
Nektar TherapeuticsCompletedAdvanced Cancer | Metastatic Solid TumorsUnited States
-
Centrexion TherapeuticsCompletedOsteoarthritis of the KneeUnited States
-
Cytori TherapeuticsCompletedMyocardial IschemiaUnited States
-
Cytori TherapeuticsCompletedMyocardial IschemiaUnited States
-
Prexton TherapeuticsCompleted
-
Cognition TherapeuticsCompleted
-
DNA TherapeuticsCompleted
-
Acorda TherapeuticsCompleted
-
Acorda TherapeuticsCompleted
-
Intarcia TherapeuticsCompletedType 2 DiabetesUnited States, Croatia, Latvia, Denmark, Germany
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
United TherapeuticsCompleted
-
Therapeutics, Inc.CompletedPsoriasis | Plaque PsoriasisUnited States
-
Cytori TherapeuticsWithdrawn
-
BIND TherapeuticsCompleted
-
Cytori TherapeuticsWithdrawnCoronary Artery Disease | Heart Failure
-
Cytori TherapeuticsCompleted
-
BIND TherapeuticsCompletedCancer | Metastatic Cancer | Solid TumorsUnited States
-
United TherapeuticsWithdrawnPulmonary Fibrosis | Pulmonary HypertensionUnited States
-
Acorda TherapeuticsCompletedIschemic StrokeUnited States
-
Vicus TherapeuticsUnknown
-
Noven TherapeuticsCompleted
-
Intarcia TherapeuticsCompleted
-
Proteon TherapeuticsCompletedChronic Kidney DiseaseUnited States
-
Aerpio TherapeuticsCompletedDiabetic Macular Edema (DME)United States
-
United TherapeuticsCompletedPulmonary Arterial HypertensionUnited States, Puerto Rico
-
Alaunos TherapeuticsCompletedBreast Cancer Nos Metastatic RecurrentUnited States
-
Alaunos TherapeuticsCompleted
-
Pulse TherapeuticsTerminated
-
Summit TherapeuticsCompletedDuchenne Muscular DystrophyUnited Kingdom
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type 2United States
-
Guided TherapeuticsUnknown
-
Halozyme TherapeuticsCompleted
-
Chelsea TherapeuticsCompletedIntradialytic HypotensionUnited States
-
Acorda TherapeuticsCompletedCerebral Palsy (CP)United States
-
Ocera TherapeuticsCompletedMild Hepatic EncephalopathyUnited States
-
Ocera TherapeuticsCompletedIrritable Bowel SyndromeUnited States, Belgium
-
Mateon TherapeuticsTerminatedAnaplastic Thyroid CancerUnited States, India, Belarus, Bulgaria, Egypt, Israel, Italy, Poland, Romania, Russian Federation, Ukraine, United Kingdom
-
Chelsea TherapeuticsTerminatedStudy To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome (CFS201)Chronic Fatigue Syndrome | Orthostatic Hypotension | Neurally Mediated Hypotension | Neurogenic Orthostatic HypotensionUnited States